MUMBAI, India, June 13 -- Intellectual Property India has published a patent application (202517048900 A) filed by Eli Lilly And Company, Indianapolis, on May 21, for 'glucagon-like peptide 1 receptor agonists.'
Inventor(s) include Chen, Qi; Fields, Todd; Ghanekar, Pushkar Gajendra; Hammill, Jared Thomas; and Woerly, Eric Michael.
The application for the patent was published on June 13, under issue no. 24/2025.
According to the abstract released by the Intellectual Property India: "In an embodiment, the present invention provides a compound of the formula: or a pharmaceutically acceptable salt thereof, and methods of using this compound for treating type II diabetes mellitus."
The patent application was internationally filed on Nov. 15,...